Infection control recommendations for patients with cystic fibrosis

Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission

Lisa Saiman, Jane Siegel

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Infection Control Recommendations for Patients With Cystic Fibrosis: Microbiology, Important Pathogens, and Infection Control Practices to Prevent Patient-to-Patient Transmission updates, expands, and replaces the consensus statement, Microbiology and Infectious Disease in Cystic Fibrosis published in 1994.1 This consensus document presents background data and evidence-based recommendations for practices that are intended to decrease the risk of transmission of respiratory pathogens among CF patients from contaminated respiratory therapy equipment or the contaminated environment and thereby reduce the burden of respiratory illness. Included are recommendations applicable in the acute care hospital, ambulatory, home care, and selected non-healthcare settings. The target audience includes all healthcare workers who provide care to CF patients. Antimicrobial management is beyond the scope of this document.

Original languageEnglish (US)
JournalAmerican Journal of Infection Control
Volume31
Issue number3
StatePublished - May 2003

Fingerprint

Infection Control
Microbiology
Cystic Fibrosis
Respiratory Therapy
Cost of Illness
Infectious Disease Transmission
Evidence-Based Practice
Home Care Services
Ambulatory Care
Communicable Diseases
Delivery of Health Care
Equipment and Supplies

ASJC Scopus subject areas

  • Microbiology
  • Infectious Diseases

Cite this

@article{21f657c380084c189221c5e6f0d3a817,
title = "Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission",
abstract = "Infection Control Recommendations for Patients With Cystic Fibrosis: Microbiology, Important Pathogens, and Infection Control Practices to Prevent Patient-to-Patient Transmission updates, expands, and replaces the consensus statement, Microbiology and Infectious Disease in Cystic Fibrosis published in 1994.1 This consensus document presents background data and evidence-based recommendations for practices that are intended to decrease the risk of transmission of respiratory pathogens among CF patients from contaminated respiratory therapy equipment or the contaminated environment and thereby reduce the burden of respiratory illness. Included are recommendations applicable in the acute care hospital, ambulatory, home care, and selected non-healthcare settings. The target audience includes all healthcare workers who provide care to CF patients. Antimicrobial management is beyond the scope of this document.",
author = "Lisa Saiman and Jane Siegel",
year = "2003",
month = "5",
language = "English (US)",
volume = "31",
journal = "American Journal of Infection Control",
issn = "0196-6553",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Infection control recommendations for patients with cystic fibrosis

T2 - Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission

AU - Saiman, Lisa

AU - Siegel, Jane

PY - 2003/5

Y1 - 2003/5

N2 - Infection Control Recommendations for Patients With Cystic Fibrosis: Microbiology, Important Pathogens, and Infection Control Practices to Prevent Patient-to-Patient Transmission updates, expands, and replaces the consensus statement, Microbiology and Infectious Disease in Cystic Fibrosis published in 1994.1 This consensus document presents background data and evidence-based recommendations for practices that are intended to decrease the risk of transmission of respiratory pathogens among CF patients from contaminated respiratory therapy equipment or the contaminated environment and thereby reduce the burden of respiratory illness. Included are recommendations applicable in the acute care hospital, ambulatory, home care, and selected non-healthcare settings. The target audience includes all healthcare workers who provide care to CF patients. Antimicrobial management is beyond the scope of this document.

AB - Infection Control Recommendations for Patients With Cystic Fibrosis: Microbiology, Important Pathogens, and Infection Control Practices to Prevent Patient-to-Patient Transmission updates, expands, and replaces the consensus statement, Microbiology and Infectious Disease in Cystic Fibrosis published in 1994.1 This consensus document presents background data and evidence-based recommendations for practices that are intended to decrease the risk of transmission of respiratory pathogens among CF patients from contaminated respiratory therapy equipment or the contaminated environment and thereby reduce the burden of respiratory illness. Included are recommendations applicable in the acute care hospital, ambulatory, home care, and selected non-healthcare settings. The target audience includes all healthcare workers who provide care to CF patients. Antimicrobial management is beyond the scope of this document.

UR - http://www.scopus.com/inward/record.url?scp=0037820620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037820620&partnerID=8YFLogxK

M3 - Article

VL - 31

JO - American Journal of Infection Control

JF - American Journal of Infection Control

SN - 0196-6553

IS - 3

ER -